Beyond these four, Lilly has registered additional TRIUMPH-numbered studies including trials in weight maintenance (TRIUMPH-6, NCT06859268) and chronic low back pain (TRIUMPH-7, NCT07035093) bringing the total program to eight trials, plus a separate, longer-horizon cardiovascular and kidney outcomes trial, TRIUMPH-Outcomes (NCT06383390), enrolling roughly 10,000 participants with established cardiovascular disease
A summary of the key findings is available via Beckers Cardiology: Stopping GLP-1s linked to 22% rise in heart attack risk and CNBC: Stopping GLP-1s raises cardiovascular risks: Researchers described this phenomenon as metabolic whiplash : cardiovascular protection that builds over years can be substantially reversed in a fraction of that time
Yes, when used at the recommended dose, L-Carnitine is considered safe for daily consumption with minimal L-carnitine side effects
The Importance of Addressing Weight Issues Carrying extra weight is more than an aesthetic concern
Acute Renal Failure When Exenatide is Co-Administered With Diuretics and Angiotensin II Blockers
Product Dimensions: 8.5 x 5.5 inches